Kendra Sih
BScPharm, PharmD
Investigator and Clinical Pharmacy Specialist, BC Children's Hospital
Canadian Family Physician
Smith, C. and Ng, K. and Sih, K. and McAlpine, A. and Goldman, R.D.
DOI: 10.46747/cfp.710708487Canadian Family Physician
Smith, C. and Ng, K. and Sih, K. and McAlpine, A. and Goldman, R.D.
DOI: 10.46747/cfp.710708e185Canadian Family Physician
Singla, S. and Sih, K. and Goldman, R.D.
DOI: 10.46747/cfp.6906e124Canadian Family Physician
Singla, S. and Sih, K. and Goldman, R.D.
DOI: 10.46747/cfp.6906400Paediatrics and Child Health Canada
Maki, K. and Doan, Q. and Sih, K. and Stillwell, K. and Chun, A. and Meckler, G.
DOI: 10.1093/pch/pxac054Canadian Family Physician
Sih, K. and Goldman, R.D.
Annals of Pharmacotherapy
Sih, K. and Campbell, S.G. and Tallon, J.M. and Magee, K. and Zed, P.J.
DOI: 10.1345/aph.1Q370The Canadian Journal of Hospital Pharmacy
Sam Louie (Con) and Kendra Bernard and Emily Black and Shahileen Remtulla and Erin Schwenger and Dawn Dalen (Pro) and Katherine Seto and Sarah Stabler and Victoria Su and Flora Young
DOI: 10.4212/cjhp.v63i4.93908 / 2010
Historically, BCCH only recommended phenytoin and phenobarbital as second line agents for status epilepticus. In 2021, BCCH a new algorithm was introduced which listed a choice of phenytoin, phenobarbital, levetiracetam, fosphenytoin and valproic acid as second line agents. The objective of this retrospective observational project, was to describe the use of second line anti-seizure medications with respect to the new algorithm and describe and adverse events.
Suicide is the second leading cause of death in adolescents and emergency departments are seeing visits rise for mental health reasons. Some adults studies have showed promise for sub-anesthetic doses of ketamine providing benefit to help with acute suicide ideation. The objective of this pilot RCT study was to provide information for future studies and to evaluate trail design for safety and feasibility. Youth between ages of 10–17 were randomized to an IV infusion of either low-dose ketamine, midazolam (active placebo) or 0.9% NaCl (placebo).
At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.
EXPLORE OUR RESEARCH